NASDAQ · Biotechnology

MPLT (MPLT) Stock

$12.17 -8.36% NASDAQ: MPLT Healthcare

Valuation

MetricValue
Price$12.17
Market Cap$516.45M
P/E Ratio-7.85
P/B Ratio0.05
P/S Ratio0.00
EPS (TTM)$-3.66
52-Week High$39.80
52-Week Low$9.90
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-35.15%
ROA-33.54%
ROCE-36.82%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.01
Current Ratio20.31

Annual Financials (USD)

Metric2022202320242025
Revenue$0$0$0$0
Operating Profit$-31.0M$-57.0M$-83.0M$-169.0M
Net Profit$-30.0M$-56.0M$-78.0M$-161.0M
EPS$-0.72$-1.34$-1.87$-3.66
Op Margin

Balance Sheet (USD)

Metric2022202320242025
Total Assets$39.0M$91.0M$137.0M$480.0M
Total Liabilities$19.0M$20.0M$22.0M$21.0M
Cash$28.0M$80.0M$38.0M$47.0M
Borrowings$6.0M$6.0M$7.0M$6.0M

Latest News

Sector Update: Healthcare Stocks Rise Late Afternoon MT Newswires · Jul 21, 2026 Sector Update: Healthcare MT Newswires · Jul 21, 2026 MapLight Therapeutics Seen Having Upside in Schizophrenia Trial Readout, UBS Says MT Newswires · Jul 21, 2026 Daily – Vickers Top Buyers & Sellers for 07/21/2026 Argus Research · Jul 21, 2026 Shopify downgraded, Five Below upgraded: Wall Street's top analyst calls The Fly · Jul 21, 2026

Cash Flow (USD)

Metric2022202320242025
Operating Cash Flow$-27.0M$-52.0M$-79.0M$-138.0M
Investing Cash Flow$-1.0M$-1.0M$-82.0M$-324.0M
Financing Cash Flow$0$0$-2.0M$-5.0M
Net Cash Flow$28.0M$52.0M$-42.0M$8.0M
Free Cash Flow$-27.0M$-52.0M$-80.0M$-139.0M

Valuation & Return Ratios

MetricValue
PEG Ratio
EV / EBITDA
FCF Yield-813.05%
Quick Ratio22.91
Interest Coverage
Return 1Y
Return 3Y
Return 5Y

Ownership

Insiders Held51.69%
Institutions Held56.98%
Institutions Float Held117.94%
Institutional HolderSharesReport Date
Novo Holdings A/S3,686,6222026-03-31
FCPM III Services B.V.3,226,4002026-03-31
T. Rowe Price Investment Management, Inc.2,801,9372026-03-31
Goldman Sachs Group Inc1,994,8732026-03-31
Blackrock Inc.1,339,7312026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BRTX $0.20 -2.11% -0.33 $1.83M 0.00%
DWTX $1.81 +3.14% 1.42 $3.45M 0.00%
EDSA $5.35 +1.90% -8.61 $51.54M 0.00%
ERNA $3.35 -3.46% 0.01 $1.05M 0.00%
IMRNImmuron Limited $1.13 -7.38% -2.03 $7.28M 0.00%

About MPLT

MPLT is led by CEO Christopher A. Kroeger, employs 109 people, headquartered in US, publicly traded since 2025.

MPLT stock trades at $12.17 with a market capitalization of $516.45M. The stock is valued at a price-to-earnings (P/E) ratio of -7.85, price-to-book of 0.05, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $9.90 and $39.80, and currently trades 69.4% below its 52-week high.

On profitability, MPLT generates a return on equity (ROE) of -35.15%, return on capital employed of -36.82%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides